Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells

Expert Opinion on Biological Therapy

Volumn 10, Issue 4, 2010, Pages 505-517

  Jackson, Wesley M ^a,b   Nesti, Leon J ^a,b,c   Tuan, Rocky S ^a,d  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b Department of Health and Human Services ^*  (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

MPCs; MSCs; Regenerative medicine; Skeletal muscle stem cells; Tissue engineering

Indexed keywords

LYMPHOCYTE SURFACE MARKER;

ARTICULAR CARTILAGE; BONE DISEASE; BONE GRAFT; CELL THERAPY; DEBRIDEMENT; HEART MUSCLE; HUMAN; MESENCHYMAL STEM CELL; MUSCLE TISSUE; NERVE REGENERATION; OSTEOARTHRITIS; REGENERATIVE MEDICINE; REVIEW; SKELETAL MUSCLE; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION;

ADULT; HUMANS; MESENCHYMAL STEM CELLS; MUSCLE, SKELETAL; REGENERATION;

EID: 77949464076     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712591003610606     Document Type: Review

References (117)

1. Chen F, Tuan R. Adult stem cells for cartilage tissue engineering and regeneration. Curr Rhematol Rev 2008;4:149-154.
2. Patterson TE, Kumagai K, Griffith L, Muschler GF. Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am 2008;90(Suppl 1):111-119
3. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 2007;15(2):109-116.
4. Nesselmann C, Ma N, Bieback K,et al. Mesenchymal stem cells and cardiac repair. J Cell Mol Med 2008;12(5B):1795-1810
5. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213(2):341-347 .
6. Friedenstein A, Piatetzky-Shapiro I, Petrakova K. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966;16:381-390
7. Friedenstein A, Chailakhyan R, Gerasimov U. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987;20:263-272
8. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 2001;7(6):259-264
9. Tuan R, Boland G, Tuli R. Adult mesenchymal stem cells and cell based tissue engineering. Arthritis Res Ther 2003;5:32-45
10. Khademhosseini A, Vacanti JP, Langer R. How to grow new organs. Sci Am Mag 2009;300(5):64-71
11. Place ES, Evans ND, Stevens MM. Complexity in biomaterials for tissue engineering. Nat Mater 2009;8(6):457-470 .
12. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98(5):1076-1084
13. Shake J, Gruber P, Baumgartner W,et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002;73:1919-1926
14. Min JY, Sullivan MF, Yang Y,et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg 2002;74(5):1568-1575
15. Chen J, Li Y, Katakowski M,et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 2003;73(6):778-786
16. Li Y, Chen J, Zhang CL,et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005;49(3):407-417
17. Le Blanc K, Tammik C, Rosendahl K,et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890-896
18. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009;11(4):377-391 .
19. Mias C, Lairez O, Trouche E,et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 2009;27(11):2734-2743
20. Tang YL, Zhao Q, Zhang YC,et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 2004;117(1):3-10
21. Lozito TP, Kuo CK, Taboas JM, Tuan RS. Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem 2009;107(4):714-722
22. Muschler GF, Matsukura Y, Nitto H,et al. Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin Orthop Relat Res 2005;(432):242-251
23. Gates CB, Karthikeyan T, Fu F, Huard J. Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. J Am Acad Orthop Surg 2008;16(2):68-76 .
24. Giordano A, Galderisi U, Marino I. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007; 211:27-35
25. Meliga E, Strem BM, Duckers HJ, Serruys PW. Adipose-derived cells. Cell Transplant 2007;16(9):963-970
26. Friedenstein AJ, Deriglasova UF, Kulagina NN,et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974;2(2):83-92
27. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007;9(1):204
28. Dominici M, Le Blanc K, Mueller I,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8(4):315-317
29. Gimble JM, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003;5(5):362-369
30. Mizuno H, Hyakusoku H. Mesengenic potential and future clinical perspective of human processed lipoaspirate cells. J Nippon Med Sch 2003;70(4):300-306
31. Tuli R, Li WJ, Tuan RS. Current state of cartilage tissue engineering. Arthritis Res Ther 2003;5(5):235-238
32. Kuo CK, Tuan RS. Tissue engineering with mesenchymal stem cells. IEEE Eng Med Biol Mag 2003;22(5):51-56
33. Song L, Young NJ, Webb NE, Tuan RS. Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev 2005;14(6):712-721
34. Tuli R, Tuli S, Nandi S,et al. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 2003;21(6):681-693
35. Noth U, Osyczka A, Tuli R,et al. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002;20:1060-1069
36. Nakahara H, Dennis JE, Bruder SP,et al. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 1991;195(2):492-503
37. Choi Y-S, Noh S-E, Lim S-M,et al. Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Biotechnol Lett 2008;30(4):593-601
38. Jones EA, English A, Henshaw K,et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 2004;50(3):817-827
39. Vandenabeele F, De Bari C, Moreels M,et al. Morphological and immunocytochemical characterization of cultured fibroblast-like cells derived from adult human synovial membrane. Arch Histol Cytol 2003;66(2):145-153
40. Fan J, Varshney RR, Ren L,et al. Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng B 2009;15(1):75-86
41. Jo YY, Lee HJ, Kook SY,et al. Isolation and characterization of postnatal stem cells from human dental tissues. Tissue Eng 2007;13(4):767-773
42. Gay IC, Chen S, Macdougall M. Isolation and characterization of multipotent human periodontal ligament stem cells. Orthod Craniofac Res 2007;10(3):149-160
43. Janjanin S, Djouad F, Shanti RM,et al. Human palatine tonsil: a new potential tissue source of multipotent mesenchymal progenitor cells. Arthritis Res Ther 2008;10(4):R83
44. Shih YR, Kuo TK, Yang AH,et al. Isolation and characterization of stem cells from the human parathyroid gland. Cell Prolif 2009;42(4):461-470
45. Jazedje T, Perin PM, Czeresnia CE,et al. Human fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures. J Transl Med 2009;7:46
46. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007;25(6):1384-1392
47. Lee OK, Kuo TK, Chen W-M,et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103(5):1669-1675
48. Cetrulo CL Jr. Cord-blood mesenchymal stem cells and tissue engineering. Stem Cell Rev 2006;2(2):163-168
49. Troyer DL, Weiss ML. Concise review: Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008;26(3):591-599
50. Huang G, Sonoyama W, Liu Y,et al. The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering. J Endod 2008;34(6):645-651
51. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs those from other sources: their biology and role in regenerative medicine. J Dent Res 2009;88(9):792-806
52. Zheng B, Cao B, Crisan M,et al. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 2007;25(9):1025-1034 .
53. Nesti LJ, Jackson WM, Shanti RM,et al. Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am 2008;90(11):2390-2398 .
54. Deasy BM, Huard J. Gene therapy and tissue engineering based on muscle-derived stem cells. Curr Opin Mol Ther 2002;4(4):382-389
55. Qu-Petersen Z, Deasy B, Jankowski R,et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002;157(5):851-864 .
56. Gharaibeh B, Lu A, Tebbets J,et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protocol 2008;3(9):1501-1509
57. Cao B, Zheng B, Jankowski RJ,et al. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol 2003;5(7):640-646
58. Crisan M, Deasy B, Gavina M,et al. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol 2008;86:295-309
59. Rando TA. Stem cells, ageing and the quest for immortality. Nature 2006;441(7097):1080-1086
60. Betsholtz C, Lindblom P, Gerhardt H. Role of pericytes in vascular morphogenesis. EXS 2005;(94):115-125
61. Dellavalle A, Sampaolesi M, Tonlorenzi R,et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 2007;9(3):255-267
62. Farrington-Rock C, Crofts NJ, Doherty MJ,et al. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004;110(15):2226-2232
63. Collett GD, Canfield AE. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res 2005;96(9):930-938
64. Caplan AI. All MSCs are pericytes? Cell Stem Cell 2008;3(3):229-230
65. Crisan M, Yap S, Casteilla L,et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3(3):301-313 .
66. Jackson WM, Aragon AB, Djouad F,et al. Mesenchymal progenitor cells derived from traumatized human muscle. J Tissue Eng Regen Med 2009;3(2):129-138
67. Jackson WM, Aragon AB, Nesti LJ, Tuan RS. Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res 2009;27(12):1645-1651
68. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008;2(4):313-319
69. Djouad F, Jackson WM, Bobbick BE,et al. Activin A expression regulates multipotency of mesenchymal progenitor cells. Stem Cells Res Ther; Accepted
70. Lozito T, Jackson WM, Tuan RS, Nesti LJ. Mesenchymal progenitor cells derived from traumatized muscle secrete factors that regulate angiogenesis. Trans Ortho Res Soc 2010;56:739
71. Jackson WM, Lozito TP, Djouad F,et al. Pro-regenerative functions of mesenchymal progenitor cells derived from traumatically injured muscle. Trans Ortho Res Soc 2009;56:733
72. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch 2009;76(2):56-66
73. Lee JY, Qu-Petersen Z, Cao B,et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000;150(5):1085-1100
74. Peng H, Wright V, Usas A,et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002;110(6):751-759
75. Wright V, Peng H, Usas A,et al. BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther 2002;6(2):169-178
76. Musgrave DS, Pruchnic R, Bosch P,et al. Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br 2002;84(1):120-127
77. Usas A, Ho AM, Cooper GM,et al. Bone regeneration mediated by BMP4-expressing muscle-derived stem cells is affected by delivery system. Tissue Eng A 2009;15(2):285-293
78. Noth U, Steinert A, Tuan R. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 2008;4:371-380
79. Chen F, Rousche K, Tuan R. Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2006;2:373-382
80. Matsumoto T, Kubo S, Meszaros LB,et al. The influence of sex on the chondrogenic potential of muscle-derived stem cells: implications for cartilage regeneration and repair. Arthritis Rheum 2008;58(12):3809-3819
81. Kuroda R, Usas A, Kubo S,et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2006;54(2):433-442
82. Adachi N, Sato K, Usas A,et al. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol 2002;29:1920-1930
83. Caplan AI. New era of cell-based orthopaedic therapies. Tissue Eng B Rev 2009;15(2):195-200
84. Patel S, Sherman L, Munoz J, Rameshwar P. Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp 2008;56(1):1-8 .
85. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol 2009;217(2):318-324
86. Garcia-Castro J, Trigueros C, Madrenas J,et al. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med 2008;12(6B):2552-2565
87. Newman RE, Yoo D, Leroux MA,et al. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 2009;8(2):110-123
88. Wilkey JF, Buchberger G, Saucier K,et al. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium. Mol Carcinog 2009;48(9):853-861
89. Peng H, Usas A, Olshanski A,et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 2005;20(11):2017-2027
90. Tseng SS, Lee MA, Reddi AH. Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am 2008;90(Suppl 1):92-98
91. Matsumoto T, Cooper GM, Gharaibeh B,et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum 2009;60(5):1390-1405
92. Lee SK, Wolfe SW. Peripheral nerve injury and repair. J Am Acad Orthop Surg 2000;8(4):243-252
93. Bulken-Hoover JD, Jackson WM, Ji Y,et al. Mechanisms to enhance the neurotrophic function of mesenchymal progenitor cells. Trans Ortho Res Soc 2010;56:1627
94. Koh JS, Lee JY, Lee JY. The effects of human muscle derived stem cells on the induction of peripheral nerve regeneration. Korean J Urol 2008;49(4):350-359
95. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 2002;161(3):895-907
96. Quintero AJ, Wright VJ, Fu FH, Huard J. Stem cells for the treatment of skeletal muscle injury. Clin Sports Med 2009;28(1):1-11
97. Cowin AJ, Holmes TM, Brosnan P, Ferguson MW. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds. Eur J Dermatol 2001;11(5):424-431
98. Li Y, Foster W, Deasy BM,et al. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 2004;164(3):1007-1019
99. Lu L, Saulis AS, Liu WR,et al. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 2005;201(3):391-397
100. Bedair HS, Karthikeyan T, Quintero A,et al. Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am J Sports Med 2008;36(8):1548-1554
101. Deasy BM, Gharaibeh BM, Pollett JB,et al. Long-term self-renewal of postnatal muscle-derived stem cells. Mol Biol Cell 2005;16(7):3323-3333
102. Itescu S, Schuster MD, Kocher AA. New directions in strategies using cell therapy for heart disease. J Mol Med 2003;81(5):288-296
103. Clause KC, Tinney JP, Liu LJ,et al. A three-dimensional gel bioreactor for assessment of cardiomyocyte induction in skeletal muscle derived stem cells. Tissue Eng C Methods 2009, published online 14 July 2009, doi:10.1089/ten. TEC.2009.0098
104. Haynesworth S, Goshima J, Goldberg V, Caplan A. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13:81-88
105. Payne TR, Oshima H, Sakai T,et al. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther 2005;12(16):1264-1274
106. Payne TR, Oshima H, Okada M,et al. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 2007;50(17):1677-1684
107. Okada M, Payne TR, Zheng B,et al. Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol 2008;52(23):1869-1880
108. Nieponice A, Soletti L, Guan J,et al. In-vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng A 2009, published online 6 November 2009, doi:10.1089/ten.TEA.2009.0427
109. Montzka K, Heidenreich A. Application of mesenchymal stromal cells in urological diseases. BJU Int 2009, published online 13 November 2009, doi10.1111/ j.1464-410X.2009.09077.x
110. Huard J, Yokoyama T, Pruchnic R,et al. Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther 2002;9(23):1617-1626
111. Smaldone MC, Chen ML, Chancellor MB. Stem cell therapy for urethral sphincter regeneration. Minerva Urol Nefrol 2009;61(1):27-40
112. Ho MH, Heydarkhan S, Vernet D,et al. Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds. Obstet Gynecol 2009;114(2 Pt 1):300-309
113. Usas A, Huard J. Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials 2007;28(36):5401-5406
114. Minasi MG, Riminucci M, De Angelis L,et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 2002;129(11):2773-2783
115. Uezumi A, Ojima K, Fukada S,et al. Functional heterogeneity of side population cells in skeletal muscle. Biochem Biophys Res Comm 2006;341(3):864-873
116. Peault B, Rudnicki M, Torrente Y,et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 2007;15(5):867-877
117. Laurencot CM, Ruppel S. Regulatory aspects for translating gene therapy research into the clinic. Methods Mol Biol 2009;542:397-421